Literature DB >> 18199657

Selective downregulation of rhesus macaque and sooty mangabey major histocompatibility complex class I molecules by Nef alleles of simian immunodeficiency virus and human immunodeficiency virus type 2.

M Quinn DeGottardi1, Anke Specht, Benjamin Metcalf, Amitinder Kaur, Frank Kirchhoff, David T Evans.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) Nef downregulates HLA-A and -B molecules, but not HLA-C or -E molecules, based on amino acid differences in their cytoplasmic domains to simultaneously evade cytotoxic T lymphocyte (CTL) and natural killer cell surveillance. Rhesus macaques and sooty mangabeys express orthologues of HLA-A, -B, and -E, but not HLA-C, and many of these molecules have unique amino acid differences in their cytoplasmic tails. We found that these differences also resulted in differential downregulation by primary simian immunodeficiency virus (SIV) SIV(smm/mac) and HIV-2 Nef alleles. Thus, selective major histocompatibility complex class I downregulation is a conserved mechanism of immune evasion for pathogenic SIV infection of rhesus macaques and nonpathogenic SIV infection of sooty mangabeys.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199657      PMCID: PMC2258998          DOI: 10.1128/JVI.02102-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation.

Authors:  H Akari; S Arold; T Fukumori; T Okazaki; K Strebel; A Adachi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.

Authors:  T Swigut; A J Iafrate; J Muench; F Kirchhoff; J Skowronski
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

4.  Mamu-I: a novel primate MHC class I B-related locus with unusually low variability.

Authors:  J A Urvater; N Otting; J H Loehrke; R Rudersdorf; I I Slukvin; M S Piekarczyk; T G Golos; A L Hughes; R E Bontrop; D I Watkins
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  A high incidence of Shigella-induced arthritis in a primate species: major histocompatibility complex class I molecules associated with resistance and susceptibility, and their relationship to HLA-B27.

Authors:  J A Urvater; S N McAdam; J H Loehrke; T M Allen; J L Moran; T J Rowell; S Rojo; J A López de Castro; J D Taurog; D I Watkins
Journal:  Immunogenetics       Date:  2000-04       Impact factor: 2.846

6.  Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression.

Authors:  D T Evans; P Jing; T M Allen; D H O'Connor; H Horton; J E Venham; M Piekarczyk; J Dzuris; M Dykhuzen; J Mitchen; R A Rudersdorf; C D Pauza; A Sette; R E Bontrop; R DeMars; D I Watkins
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection.

Authors:  A Kaur; L Alexander; S I Staprans; L Denekamp; C L Hale; H M McClure; M B Feinberg; R C Desrosiers; R P Johnson
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

8.  Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.

Authors:  Otto O Yang; Phuong Thi Nguyen; Spyros A Kalams; Tanya Dorfman; Heinrich G Göttlinger; Sheila Stewart; Irvin S Y Chen; Steven Threlkeld; Bruce D Walker
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 9.  Species-specific evolution of MHC class I genes in the higher primates.

Authors:  E J Adams; P Parham
Journal:  Immunol Rev       Date:  2001-10       Impact factor: 12.988

10.  Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques.

Authors:  J Münch; N Stolte; D Fuchs; C Stahl-Hennig; F Kirchhoff
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more
  17 in total

1.  Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.

Authors:  Anke Specht; Amalio Telenti; Raquel Martinez; Jacques Fellay; Elizabeth Bailes; David T Evans; Mary Carrington; Beatrice H Hahn; David B Goldstein; Frank Kirchhoff
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

2.  Immunogenetic characterization of a captive colony of sooty mangabeys (Cercocebus atys) used for SIV research.

Authors:  Geary R Smith; Liesel Bauer; Maria M Crane; Zachary P Johnson
Journal:  J Med Primatol       Date:  2015-01-21       Impact factor: 0.667

3.  Down-modulation of CD8αβ is a fundamental activity of primate lentiviral Nef proteins.

Authors:  Anke Heigele; Michael Schindler; Clement W Gnanadurai; Jolie A Leonard; Kathleen L Collins; Frank Kirchhoff
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques.

Authors:  Susanna L Lamers; David J Nolan; Brittany D Rife; Gary B Fogel; Michael S McGrath; Tricia H Burdo; Patrick Autissier; Kenneth C Williams; Maureen M Goodenow; Marco Salemi
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

5.  Diversification of Bw4 Specificity and Recognition of a Nonclassical MHC Class I Molecule Implicated in Maternal-Fetal Tolerance by Killer Cell Ig-like Receptors of the Rhesus Macaque.

Authors:  Priyankana Banerjee; Moritz Ries; Sanath Kumar Janaka; Andres G Grandea; Roger Wiseman; David H O'Connor; Thaddeus G Golos; David T Evans
Journal:  J Immunol       Date:  2018-09-19       Impact factor: 5.422

6.  High viremia is associated with high levels of in vivo major histocompatibility complex class I Downregulation in rhesus macaques infected with simian immunodeficiency virus SIVmac239.

Authors:  Thomas C Friedrich; Shari M Piaskowski; Enrique J León; Jessica R Furlott; Nicholas J Maness; Kimberly L Weisgrau; Caitlin E Mac Nair; Andrea M Weiler; John T Loffredo; Matthew R Reynolds; K Y Williams; Yann C Klimentidis; Nancy A Wilson; David B Allison; Eva G Rakasz
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

7.  Characterization of MHC class I alleles in sooty mangabeys as a tool for evaluating cellular immunity in natural hosts of SIV infection.

Authors:  Zichun Wang; Benjamin Metcalf; Melissa Kasheta; Caitlin Kasala-Hallinan; Dollnovan Tran; R Paul Johnson; James G Else; Julie Karl; David O'Connor; Cristian Apetrei; Amitinder Kaur
Journal:  Immunogenetics       Date:  2015-07-01       Impact factor: 2.846

8.  Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.

Authors:  Francis Mwimanzi; Mako Toyoda; Macdonald Mahiti; Jaclyn K Mann; Jeffrey N Martin; David Bangsberg; Mark A Brockman; Philip Goulder; Frank Kirchhoff; Zabrina L Brumme; Thumbi Ndung'u; Takamasa Ueno
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

9.  TE-domestication and horizontal transfer in a putative Nef-AP1mu mimic of HLA-A cytoplasmic domain re-trafficking.

Authors:  Joseph S Murray; Elaina H Murray
Journal:  Mob Genet Elements       Date:  2016-04-12

10.  Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Authors:  Bin Jia; Ruth Serra-Moreno; William Neidermyer; Andrew Rahmberg; John Mackey; Ismael Ben Fofana; Welkin E Johnson; Susan Westmoreland; David T Evans
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.